Watch: Mr Tohlang Sehloho discusses the COVID 19 vaccine Janssen update on eNCA

GUIDANCE ON THE USE OF THE JANSSEN AD26.COV2.S (COVID-19) VACCINE IN PREGNANT AND LACTATING WOMEN- A DISCUSSION BY MR TOHLANG SEHLOHO, SENIOR MANAGER: CLINIC...

Watch: Mr Tohlang Sehloho discusses updates on the Covid 19 Vaccine Jansen on Newsroom Afrika.

GUIDANCE ON THE USE OF THE JANSSEN AD26.COV2.S (COVID-19) VACCINE IN PREGNANT AND LACTATING WOMEN- A DISCUSSION BY MR TOHLANG SEHLOHO, SENIOR MANAGER: CLINIC...

Latest News:

Guidance on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine in pregnant and lactating women

Read more:https://bit.ly/3b74sZp
#SAHPRA #COVID19 #Janssen #pregnancy

Pregnant women are at higher risk of severe COVID-19 compared with women of childbearing age who are not pregnant, and COVID-19 has been associated with an increased risk of preterm birth.

Have you downloaded the Med safety app? Please share your thoughts on how you find the app. Yo can do this by leaving your comments in the comments section below, or sending an email to media@sahpra.org.za.

https://medsafety.sahpra.org.za/ ... See more

Here are the benefits if using the Med Safety mobile app.

New Mobile app:

SAHPRA is pleased to announce the launch of the Med Safety App. The Med Safety App is a mobile application (App) that is designed to simplify and promote the reporting of suspected adverse drug reactions (ADRs), including adverse events following immunisation (AEFIs) by both the public and healthcare providers. The App also allows the public and healthcare providers to learn about medicine safety news from SAHPRA, thereby creating an awareness of medicines; their potential adverse effects and pharmacovigilance.

Read more: https://bit.ly/2Qp7Kjc

#SAHPRA #mobileapp #ADRs #healthcareworkers ... See more

Press release:

SAHPRA refutes claims made by the President of the Black Farmers Association of South Africa (BFASA) that SAHPRA has an inclination towards White bias.

Read more:https://bit.ly/32ySDq3
#SAHPRA #cannabis #thc #cbd ... See more

SAHPRA refutes claims made by the President of the Black Farmers Association of South Africa (BFASA) that SAHPRA has an inclination towards White bias.

Watch: The CEO discusses the Sisonke Phase 3B Implementation study update with Steven Grootes on Newzroom Afrika

The CEO discusses the Sisonke Phase 3B Implementation study update with Steven Grootes on Newzroom Afrika

Latest News:

SAHPRA has engaged with the Sisonke Phase 3B Implementation Study team and Janssen Pharmaceutica. The focus of the engagement was on the safety data reported from the Sisonke study, following administration of the COVID-19 vaccine Janssen, as well as the adverse events reported in the United States of America.

Based on their review of the available data, SAHPRA has recommended that the pause in the Sisonke study be lifted, provided that specific conditions are met.

Read more:https://bit.ly/3ddMDsX
#SAHPRA #Janssen #COVID19 #vaccinecovid19 ... See more

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study.

Press release:

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study. This study involves the administration of the COVID-19 vaccine Janssen, which is also referred to as the Johnson and Johnson (J&J) vaccine. Based on these data, no major safety concerns have been identified. No causal relationship between vaccination and the development of blot clots is evident at this stage.

Read more:https://bit.ly/3ddMDsX
#SAHPRA #Janssen #COVID19 #vaccinecovid19 ... See more

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study.